Methylprednisolone Therapy in Patients with Severe Alcoholic Hepatitis

Abstract

Methylprednisolone therapy decreases short-term mortality in patients with severe alcoholic hepatitis manifested either by spontaneous hepatic encephalopathy or a markedly elevated discriminant function value.